A longitudinal investigation of a larger number of TTRv carriers with a variety of genotypes is warranted to specify the dynamics of NfL in TTRv carriers that progress to symptomatic ATTRv amyloidosis patients over time. The gene discussed is NEFL; the disease is amyloidosis.